Testing effectiveness (Phase 2)UnknownNCT00026442What this trial is testingCapecitabine in Treating Women With Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Pharmatech Oncology
Not applicableStudy completedNCT00362973What this trial is testingPET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast CancerWho this might be right forBreast Cancer University of Washington 42
Not applicableStudy completedNCT00949013What this trial is testingS9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG-9313Who this might be right forBreast Cancer SWOG Cancer Research Network 1,600
Large-scale testing (Phase 3)Study completedNCT00265759What this trial is testingExemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast CancerWho this might be right forBreast Cancer Alliance for Clinical Trials in Oncology 622
Not applicableActive Not RecruitingNCT02079662What this trial is testingThe Role of Lifestyle Factors in Breast Cancer-Related OutcomesWho this might be right forStage II Breast Cancer AJCC v6 and v7Stage IIA Breast Cancer AJCC v6 and v7Stage IIB Breast Cancer AJCC v6 and v7+4 more M.D. Anderson Cancer Center 110
Early research (Phase 1)Study completedNCT00010023What this trial is testingCapecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forCancer NYU Langone Health
Large-scale testing (Phase 3)Not Yet RecruitingNCT07829549What this trial is testingPhase III Study of RC148 Plus Chemotherapy Versus Tislelizumab Plus Chemotherapy as First-Line Treatment for Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic AlterationsWho this might be right forPreviously Untreated Locally Advanced (IIIB/IIIC) or Metastatic (IV) e Nsq NSCLC Without Actionable Genomic Alterations RemeGen Co., Ltd. 540
Testing effectiveness (Phase 2)Study completedNCT00834678What this trial is testingBendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast CancerWho this might be right forBreast Cancer Ohio State University Comprehensive Cancer Center 11
Early research (Phase 1)Looking for participantsNCT06324240What this trial is testingPersonalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast CancerWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+24 more Emory University 18
Testing effectiveness (Phase 2)Looking for participantsNCT07104149What this trial is testingNeoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical CancerWho this might be right forFemale, Age ≥ 18 Years OldNo Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/ImmunotherapyECOG Score of 0-1+6 more The First Affiliated Hospital of Zhengzhou University 29
Not applicableApproved For MarketingNCT00338247What this trial is testingEAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast CancerWho this might be right forNeoplasms, Breast Novartis
Testing effectiveness (Phase 2)Ended earlyNCT06984328What this trial is testingStudy of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07)Who this might be right forCutaneous MelanomaRelapsed/Refractory, Locally Advanced Unresectable Melanoma (Stage IIIB, IIIC, or IIID)Metastatic Cutaneous Melanoma (Stage IV) Genmab 1
Testing effectiveness (Phase 2)Ended earlyNCT02587650What this trial is testingCapmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV MelanomaWho this might be right forALK Fusion Protein ExpressionBRAF wt AlleleInvasive Skin Melanoma+12 more University of California, San Francisco 1
Not applicableLooking for participantsNCT07050940What this trial is testingAnti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma StudyWho this might be right forMelanoma Metastatic Azienda Ospedaliera di Perugia 35
Testing effectiveness (Phase 2)Study completedNCT01739218What this trial is testingBevacizumab (Avastin) in Neoadjuvant Therapy in Participants With International Federation of Gynecology and Obstetrics (FIGO) Stage IIIC/IV Ovarian, Tubal, or Peritoneal Cancer, Initially UnresectableWho this might be right forOvarian Cancer Hoffmann-La Roche 99
Testing effectiveness (Phase 2)Study completedNCT00693719What this trial is testingIrinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast CancerWho this might be right forBreast Cancer University of Arizona 31
Early research (Phase 1)Ended earlyNCT01197664What this trial is testingParicalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in SurgeryWho this might be right forMucinous Adenocarcinoma of the RectumStage IIA Rectal CancerStage IIB Rectal Cancer+3 more Wake Forest University Health Sciences 2
Not applicableLooking for participantsNCT05010109What this trial is testingCardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized ChemoradiationWho this might be right forLocally Advanced Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+2 more M.D. Anderson Cancer Center 100
Early research (Phase 1)Study completedNCT03725436What this trial is testingALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid TumorsWho this might be right forAdvanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+12 more M.D. Anderson Cancer Center 28
Not applicableStudy completedNCT04662645What this trial is testingEmbedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their CaregiversWho this might be right forCaregiverMalignant Pleural NeoplasmMetastatic Thymic Carcinoma+9 more Ohio State University Comprehensive Cancer Center 68